GPT and metabolic dysfunction-associated steatotic liver disease: Compared to non‐NAFLD controls lean NAFLD patients had significantly higher mean values of ALT (MD 8.12 U/L, 95% CI 6.21–10.02, Figure S15A), AST (MD 2.72 U/L, 95% 1.91–3.63, Figure S16A), and GGT (MD 11.21 U/L, 95% CI 9.02–13.40, Figure S17A).